Literature DB >> 16949791

X chromosome gene expression in human tissues: male and female comparisons.

Zohreh Talebizadeh1, Stephen D Simon2, Merlin G Butler3.   

Abstract

About 25% of X-linked genes may escape inactivation at least to some degree. However, in vitro results from somatic cell hybrids may not reflect what happens in vivo. Therefore, we analyzed the female/male (F/M) gene fold expression ratio for 299 X-linked and 7795 autosomal genes from 11 different tissues from an existing in vivo microarray database. On average 5.1 and 4.9% of genes showed higher expression in females compared with 7.4 and 7.9% in males, respectively, for X-linked and autosomal genes. A trend was found for F/M gene fold ratios greater than 1.5 for several X-linked genes indicating overexpression in females among multiple tissues. Nine X-linked genes showed overexpression in females in at least 3 of the 11 studied tissues. Of the 9 genes, 6 were located on the short arm and 3 on the long arm of the X chromosome. Six of the 9 genes have previously been reported to escape X inactivation. However, in general, no consistent pattern was seen for the expression of X-linked genes between in vitro and in vivo systems. This study indicates that factors other than the X-inactivation process may impact on the expression of X-linked genes resulting in an overall similar gender expression for both X-linked and autosomal genes.

Entities:  

Mesh:

Year:  2006        PMID: 16949791     DOI: 10.1016/j.ygeno.2006.07.016

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  41 in total

1.  Strong purifying selection at genes escaping X chromosome inactivation.

Authors:  Chungoo Park; Laura Carrel; Kateryna D Makova
Journal:  Mol Biol Evol       Date:  2010-06-09       Impact factor: 16.240

Review 2.  Solving the "X" in embryos and stem cells.

Authors:  Pablo Bermejo-Alvarez; Priscila Ramos-Ibeas; Alfonso Gutierrez-Adan
Journal:  Stem Cells Dev       Date:  2012-03-06       Impact factor: 3.272

Review 3.  The evolution of X chromosome inactivation in mammals: the demise of Ohno's hypothesis?

Authors:  Eugénie Pessia; Jan Engelstädter; Gabriel A B Marais
Journal:  Cell Mol Life Sci       Date:  2013-10-31       Impact factor: 9.261

4.  Clinical Outcomes and Counselling Issues regarding Partial Trisomy of Terminal Xp in a Child with Developmental Delay.

Authors:  Karen L Sheath; Roberto L Mazzaschi; Salim Aftimos; Nerine E Gregersen; Alice M George; Donald R Love
Journal:  Sultan Qaboos Univ Med J       Date:  2013-05-09

5.  Is there any clinical relevant difference between non mosaic Klinefelter Syndrome patients with or without Androgen Receptor variations?

Authors:  Umberto Valente; Cinzia Vinanzi; Savina Dipresa; Riccardo Selice; Massimo Menegazzo; Massimo Iafrate; Carlo Foresta; Andrea Garolla
Journal:  Sci Rep       Date:  2017-06-13       Impact factor: 4.379

6.  Clustered transcripts that escape X inactivation at mouse XqD.

Authors:  Alexandra M Lopes; Sarah E Arnold-Croop; António Amorim; Laura Carrel
Journal:  Mamm Genome       Date:  2011-07-19       Impact factor: 2.957

7.  Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations.

Authors:  Jialin Xu; Payal P Khincha; Neelam Giri; Blanche P Alter; Sharon A Savage; Judy M Y Wong
Journal:  Am J Hematol       Date:  2016-11-04       Impact factor: 10.047

8.  Transcript-level expression analysis of RNA-seq experiments with HISAT, StringTie and Ballgown.

Authors:  Mihaela Pertea; Daehwan Kim; Geo M Pertea; Jeffrey T Leek; Steven L Salzberg
Journal:  Nat Protoc       Date:  2016-08-11       Impact factor: 13.491

Review 9.  Interactions between age, sex, and hormones in experimental ischemic stroke.

Authors:  Fudong Liu; Louise D McCullough
Journal:  Neurochem Int       Date:  2012-10-13       Impact factor: 3.921

Review 10.  Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review.

Authors:  Louise L C Pinto; Taiane A Vieira; Roberto Giugliani; Ida V D Schwartz
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.